[Edaily Reporter Shin Ha-yeon] MetaBiomed is set to target the global aesthetic and cosmetic surgery market with its new lineup of aesthetic products.

MetaBiomed, a company specializing in high-performance biomedical materials, announced on the 12th that it will participate in “IMCAS Asia 2026,” Asia’s largest aesthetic surgery conference, to be held in Bangkok, Thailand, starting on the 19th.

MetaBiomed will operate a dedicated exhibition booth (Booth #108) during the event and plans to showcase its new total aesthetic product lineup, including its flagship brand ‘Da:all PDO Thread,’ as well as lifting and skin booster products.

Its flagship product, Da:all, is the first domestic PDO absorbable suture to obtain European CE MDR certification. It effectively stabilizes subcutaneous tissue during minimally invasive procedures and provides long-term wound support. With five types and 336 models, it can address a wide range of clinical needs.

The company will also host an exclusive academic session titled “Da:all PDO Thread Open Session” during the event. MetaBiomed plans to present clinical data on its products to global medical experts and international buyers, while also pursuing business networking opportunities to expand its overseas partnerships.

Dr. Kim Woo-ram, a full member of the Korean Society of Plastic and Reconstructive Surgeons (KPRS) and the International Society of Plastic and Reconstructive Surgeons (IPRAS), will serve as the keynote speaker for the academic session. Drawing on his clinical experience in anti-aging and thread lifting, Dr. Kim plans to share his expertise in anatomical facial remodeling using data from both surgical and non-surgical lifting procedures. He will also introduce the clinical safety and biocompatibility of Da products, as well as practical procedural techniques applicable in clinical settings.

The session will take place on the 21st at 2:00 PM local time, and is open to any medical professionals or industry representatives visiting the venue, with no pre-registration required.

A MetaBiomed representative stated, “At a time when the K-Beauty trend is gaining global attention, we have secured an opportunity to directly showcase the excellence of our products to global medical professionals through participation in this prestigious international aesthetic surgery conference.” They added, “We will do our utmost to use this event as a stepping stone to enhance our academic credibility based on clinical evidence and translate this into tangible results for our overseas aesthetic business.”

Meanwhile, MetaBiomed, established in 1990, is a medical device company specializing in biodegradable sutures and dental materials. Recently, the company has been expanding its portfolio of medical beauty products—including PDO threads, skin boosters, and fillers—based on its proprietary biopolymer technology. Leveraging a global network that supplies products to 110 countries worldwide, the company continues to grow as a provider of high-performance biomedical materials.